Message #2 From:
Stock News Bot Date: November 6, 2006 09:19:00 AM
ABPH News Advanced BioPhotonics Completes $2 Million Financing
BOHEMIA, N.Y.--(BUSINESS WIRE)--Advanced BioPhotonics Inc. (OTCBB: ABPH) a developer of next
generation medical imaging applications using advanced infrared
technology announced today that it has closed on a $2 million financing
with institutional investors. The terms of the financing are disclosed
in a Form 8-K filing made with the Securities and Exchange Commission on
November 3, 2006.
Denis O’Connor, CEO of Advanced BioPhotonics,
commented “We are very pleased that our
investors continue to support the company in its efforts to
commercialize its technology. While our technology platform has promise
in a multitude of applications, we continue to focus on applications
with the nearest term commercialization opportunities. We believe that
with this additional financing, the company will be able to make
significant progress towards commercialization.”
About Advanced BioPhotonics
Advanced BioPhotonics Inc. (OTCBB: ABPH) headquartered in Bohemia, New
York, is an innovative developer of medical imaging applications using
advanced infrared technology. Advanced BioPhotonics provides imaging
technology for clinicians and researchers for use in the detection and
management of diseases affecting perfusion or reperfusion of tissue or
organs.
Advanced BioPhotonics's mission is to improve the quality and
cost-effectiveness of healthcare services and research through
identifying, acquiring and adapting high-resolution infrared technology
for biomedical applications. For more information about the Company and
its technology, please visit http://www.advancedbp.com/.
This press release includes statements that may constitute
"forward-looking" statements, usually containing the words "believe",
"estimate", "project", "expect" or similar expressions. These statements
are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Forward-looking statements
inherently involve risks and uncertainties that could cause actual
results to differ materially from the forward-looking statements.
Factors that would cause or contribute to such differences include, but
are not limited to, continued acceptance of the Company's products and
services in the marketplace, the ability of the Company to develop
effective new products and receive governmental approvals of such
products, competitive factors, dependence upon third-party vendors, and
other risks detailed in the Company's periodic report filings with the
Securities and Exchange Commission. By making these forward-looking
statements, the Company undertakes no obligation to update these
statements for revisions or changes after the date of this release.
